Luye Pharma USA is a professional pharmaceutical company based on innovative R&D, and comprehensive clinical and regulatory strategy. The sub-operating company in Boston was was founded in 2016, and the sub-operating company in Princeton, in 2012. Both sites have state-of-the-art facilities. The holding-company, Luye Pharma LTD, has R&D centers located in China, the USA and Europe, as well as overseas branch offices in Hong Kong, Singapore and Malaysia with approximately 4,000 employees. Luye Pharma USA consists of two groups: -Luye Boston R&D is a newly established research facility focusing on cutting-edge biotechnology and pharmaceutical therapeutics. -Luye Princeton is the US clinical and regulatory arm of Luye, as well as a PE hub for the United States.
| Website | http://luyeusa.com/ |
| Revenue | $6 million |
| Employees | 7 (1 on RocketReach) |
| Founded | 2012 |
| Technologies |
JavaScript
,
HTML
,
Nginx
+6 more
(view full list)
|
| Industry | Pharmaceuticals, Manufacturing General, Manufacturing |
| Keywords | Pharmaceutical Research, Medicine, Drug Development, Clinical Trials, Innovation, Therapeutics, Regulatory Affairs, New Drug Applications, Drug Discovery, Biotechnology, Fda Submissions, Clinical Research, Prescription Drugs, Medical Science, Generic Medicines, Drug Manufacturing, Healthcare, Global Healthcare |
| Competitors | Johnson & Johnson, Roche, Novartis, Merck & Co., Inc., Pfizer, AstraZeneca, Bristol Myers Squibb, Amgen, Gilead Sciences, Lilly India +43 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Luye Life Sciences USA employee's phone or email?
The Luye Life Sciences USA annual revenue was $6 million in 2026.
1 people are employed at Luye Life Sciences USA.
The NAICS codes for Luye Life Sciences USA are [32, 325].
The SIC codes for Luye Life Sciences USA are [28, 283].